Abstract
Introduction:
The objective of this study was to report the impact of exacerbations on health-related quality of life (HRQL) and health utility in patients with moderate to severe asthma (BTS levels 4 & 5) in the UK.
Materials and Methods:
Prospective data regarding HRQL were collected (n=112) using the EQ-5D, mini Asthma Quality of Life Questionnaire (mAQLQ), and Asthma Symptom Utility (ASUI) measures.
Results:
The mAQLQ, EQ-5D and ASUI were all significantly worse for patients suffering exacerbations (p<0.001) compared to those without. There was also evidence of a further HRQL decrement in those patients who had been admitted to hospital as a result of an exacerbation during the four-week study.
Conclusions:
This study documents the impact of asthma exacerbations on HRQL in patients with moderate to severe asthma. There was some evidence of floor effects on the mAQLQ and ASUI in their ability to capture the impact of exacerbations. These study data are suitable for use in economic evaluations.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
There are no existing or potential conflicts of interest to declare.
Rights and permissions
About this article
Cite this article
Lloyd, A., Price, D. & Brown, R. The impact of asthma exacerbations on health-related quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J 16, 22–27 (2007). https://doi.org/10.3132/pcrj.2007.00002
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.3132/pcrj.2007.00002
This article is cited by
-
Patient experience of moderate asthma attacks: qualitative research in the USA and Germany
Journal of Patient-Reported Outcomes (2022)
-
Measurement properties of the EQ-5D-Y administered through a smartphone app in children with asthma: a longitudinal questionnaire study
Health and Quality of Life Outcomes (2022)
-
Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma
BMC Pulmonary Medicine (2021)
-
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
Allergy, Asthma & Clinical Immunology (2021)
-
The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data
Journal of Patient-Reported Outcomes (2021)